A Nishiyama Seimen employee works at its factory in Sapporo.
BUSINESS / Companies / FOCUS
Oct 26, 2025
Japanese firms keep expanding in Germany's North Rhine-Westphalia
Around 650 Japanese companies maintain a presence in the area, with the latest arrivals varying from tech startups to noodle makers.
Former Binance CEO Changpeng "CZ" Zhao arrives at federal court in Seattle, Washington, in April 2024.
BUSINESS / Companies
Oct 24, 2025
Crypto billionaire gets pardon after firm supports Trump family venture
U.S. President Donald Trump said 'a lot of people' had told him convicted Binance co-founder Changpeng 'CZ' Zhao wasn't guilty.
The Shipbuilders’ Association of Japan announced plans to invest ¥350 billion in capital expenditures to double shipbuilding output by 2035.
BUSINESS / Companies
Oct 24, 2025
Japan shipbuilders to invest ¥350 billion to double output
The Shipbuilders’ Association of Japan is also preparing for Japan-U.S. cooperation in the sector.
A wafer fab owned by Nexperia. The Dutch chipmaker has warned Japanese auto parts makers about a potential supply shortage.
BUSINESS / Companies
Oct 23, 2025
Nexperia warns Japanese automakers of uncertain chip supply
The Dutch government seized control of Nijmegen-based Nexperia earlier this month in an unprecedented step intended to secure European access to the components made by the company.
Nomura Holdings CEO Kentaro Okuda
BUSINESS / Companies
Oct 23, 2025
Nomura CEO seeks to tap Japan investors’ private market bets
Kentaro Okuda is looking to Japanese investors who are seeking private markets as a way to diversify their assets.
Hitoshi Inoue, head of Bank of Yokohama’s markets business
BUSINESS / Companies
Oct 23, 2025
Top Japan local bank ready to boost JGB buying when BOJ pivots
Bank of Yokohama is prepared to pile back into the domestic debt market when the central bank’s peak interest rate is in sight.
A Novo Nordisk office in Bagsvaerd, on the outskirts of Copenhagen
BUSINESS / Companies
Oct 22, 2025
Novo's board bust-up to sharpen drugmaker's focus on U.S. consumers
The Danish drugmaker that initially soared on the success of its obesity drug has lost its market lead to U.S. rival Eli Lilly and cheaper copycats.

Longform

Mamoru Iwai, stationmaster of Keisei Ueno Station, says that, other than earthquake-proofing, the former Hakubutsukan-Dobutsuen (Museum-Zoo) Station has remained untouched.
Inside Tokyo's 'phantom' stations — and the stories they tell